corbevax | Zee News

Advertisement

Corbevax News

12 Aug 2022

Corbevax likely to be available at vaccination centres from today, check PRICE

Corbevax is likely to be available at vaccination centres from today It is India’s first Heterologous Covid-19 booster vaccine The price of Corbevax for private vaccination centres is Rs 250, inclusive of the GST

Biological E Corbevax vaccine

11 Aug 2022

India widens Covid-19 vaccine basket, Corbevax to be available as booster dose

Corbevax will be available through the COWIN App in both public and private vaccination centres from Friday. The price of the vaccine is Rs 400, including taxes and administrative charges. The pharmaceutical company (BE) has, so far, delivered 10 crore doses of Corbevax to the Centre.

10 Aug 2022

Corbevax cleared as Covid booster dose for Covaxin, Covishield recipients

Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield Health Ministry's approval is based on the recommendations made by the NTG Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the COVID-19 immunisation programme.

04 Jun 2022

CORBEVAX becomes first vaccine in India to get approval for COVID booster dose

CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose. People who are 18 years & above & have already taken two doses of either COVISHIELD or COVAXIN can now receive a dose of CORBEVAX. The vaccine can be taken after 6 months of two doses of Covaxin or Covishield vaccines for restricted use in emergency situation.

21 Apr 2022

Covid-19: Expert panel recommends emergency use of Corbevax jab for kids

An expert panel of India's central drug authority has recommended granting emergency use authorisation for children’s vaccine. Biological E's COVID-19 vaccine Corbevax for children in the five to 11 years age group. India began inoculating children aged 12-14 on March 16.

Children vaccination

16 Mar 2022

DNA: 'Raksha Kavach' to protect children above 12 years from corona

India has entered a new era in the case of Covid. And in this new era, children of 12 to 14 years have started getting the vaccine of Covid. Children are being given the Corbevax vaccine made in India, which has been developed by Hyderabad-based company, Biological E. In the trial, this vaccine has been found to be up to 90 percent effective and it is also capable of defeating beta and delta variants of corona.

16 Mar 2022

‘Get vaccinated’: PM Modi urges children aged 12-14 to take vaccine shots

The appeal from the Prime Minister came as Covid-19 vaccination for all beneficiaries in the 12-14 age group began from Wednesday (March 16, 2022) at all government Covid vaccination centres.

16 Mar 2022

Covid-19 vaccination for kids aged 12-14 years begins today

Rajesh Bhushan, Union Health Secretary, in a virtual meeting with all states and UTs on Tuesday, said that the online registration for vaccination will start at 9 AM.

15 Mar 2022

Centre issues guidelines for Covid vaccination of 12-14 years age group

Precaution dose for all aged 60 and above will begin on March 16. Beneficiaries born in 2010 or before can register for the 12-14 age group category. There are 4.7 crore children in this age group eligible for vaccination.

15 Mar 2022

Covid vaccination drive for 12-14: Know which shots will be given to your kids

The Corbevax vaccine is administered through an intramuscular route with two doses scheduled 28 days apart and is stored at 2-8 degrees Celsius temperature.

09 Mar 2022

Biological E seeks approval for Corbevax for 5-12 age group, details here

Approval is awaited for 5-12 years age group The DGCI is expected to give the final EUA to Corbevax soon

21 Feb 2022

Corbevax receive emergency use authorisation for 12-18 years age group

Corbevax is given in two doses scheduled 28 days apart The government has not taken a decision yet on vaccinating those aged below 15 years

15 Feb 2022

Corbevax is safe, will be administered in two doses, says NTAGI chief

Corbevax will have 2 primary doses just like other vaccines in India: Dr Arora

14 Feb 2022

DCGI grants emergency use authorisation to Corbevax for 12-18 year age group

Corbevax is India`s first indigenously developed RBD protein sub-unit vaccine against Covid-19 India has administered both doses of Covid vaccines over 1.5 crore adolescents of 15 to 18 age group

05 Feb 2022

Centre places purchase order for 5 crore Corbevax vaccine doses: Report

Biological E is expected to deliver the doses in the month of February Biological E has also received permission for heterologous booster dose trials

29 Dec 2021

Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines

Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.

COVID-19 vaccine

28 Dec 2021

As India approves Corbevax, here’s all you need to know about the new vaccine

CORBEVAX is India’s first indigenously developed protein sub-unit COVID-19 vaccine. CORBEVAX is a “recombinant protein sub-unit” vaccine.

28 Dec 2021

Corbevax and Covovax Vaccine Approved

2 vaccines and 1 drug related to corona have been approved. The Corbevax and Covovax vaccines have been approved.

28 Dec 2021

India gets two more COVID-19 vaccines, CORBEVAX and COVOVAX receive EUA nod

Molnupiravir, an anti-viral drug, has also been approved for restricted use in an emergency situation.

Biological E Corbevax vaccine

03 Sep 2021

Biological E gets nod for phase 2/3 clinical trial for vaccine on children

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents Corbevax, an RBD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology.

Loading...

NEWS ON ONE CLICK